Occupational cohort study of current and former workers exposed to chrysotile in mine and processing facilities in Asbest, the Russian Federation: Cohort profile of the Asbest Chrysotile Cohort study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 15 04 2020
accepted: 03 07 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 24 9 2020
Statut: epublish

Résumé

A historical cohort study in workers occupationally exposed to chrysotile was set up in the town of Asbest, the Russian Federation, to study their cause-specific mortality, with a focus on cancer. Chrysotile has different chemical and physical properties compared with other asbestos fibres; therefore it is important to conduct studies specifically of chrysotile and in different geographical regions to improve the knowledge about its carcinogenicity. Setting was the town of Asbest, Sverdlovsk oblast, the Russian Federation. Participants were all current and former employees with at least one year of employment between 1/1/1975 and 31/12/2010 in the mine, enrichment factories, auto-transport and external rail transportation departments, the central laboratory, and the explosives unit of the company. Of the 35,837 cohort members, 12,729 (35.5%) had died (2,373 of them of cancer, including 10 of mesothelioma), 18,799 (52.5%) were known to be alive at the end of the observation period (2015), and 4,309 (12.0%) were censored before the end of 2015. Mean follow-up duration was 21.7 years in men and 25.9 years in women. The mean age at death was 59.4 years in men and 66.5 years in women. This is the largest occupational cohort of chrysotile workers to date, and the only one with a large proportion of exposed female workers.

Identifiants

pubmed: 32726334
doi: 10.1371/journal.pone.0236475
pii: PONE-D-20-10832
pmc: PMC7390538
doi:

Substances chimiques

Asbestos, Serpentine 0
Asbestos 1332-21-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0236475

Déclaration de conflit d'intérêts

Dr Kovalevskiy and Dr Kashanskiy reported receiving, on behalf of their institutes and personally through consulting firms, payments from companies to evaluate exposure to asbestos and risk of asbestos-related disease in those workplaces. All other authors have no competing interests to declare. For full transparency, Dr Kovalevskiy reported participation as an occupational and environmental health expert as part of the delegation of the Russian Ministry of Health at multiple World Health Assembly meetings as well as at the Conference of the Parties to the Basel and Rotterdam Conventions. Dr Kovalevskiy and Dr Kashansky reported attending meetings organized by the International Chrysotile Association and reported that all expenses for attendance were paid by their respective institutes. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

PLoS One. 2013 Aug 21;8(8):e71899
pubmed: 23991003
Ann Work Expo Health. 2017 Aug 1;61(7):797-808
pubmed: 28810689
Am J Ind Med. 2000 Apr;37(4):327-33
pubmed: 10706743
Epidemiology. 2017 Mar;28(2):288-299
pubmed: 28141674
Cancer Causes Control. 2014 May;25(5):615-24
pubmed: 24658968
Ind Health. 2001 Apr;39(2):51-6
pubmed: 11341558
Cancer Epidemiol. 2013 Aug;37(4):440-5
pubmed: 23608525
Methods Inf Med. 2020 Jun 14;:
pubmed: 32535878
Am J Ind Med. 1999 Sep;Suppl 1:142-4
pubmed: 10519815
Occup Environ Med. 2016 May;73(5):290-9
pubmed: 26715106
Ann Occup Hyg. 1997 Dec;41(6):707-19
pubmed: 9375529
Ann Occup Hyg. 1997 Jan;41(1):13-36
pubmed: 9072947
Br J Cancer. 1999 Feb;79(3-4):666-72
pubmed: 10027347
Am J Ind Med. 2020 Feb;63(2):135-145
pubmed: 31821579
Br J Cancer. 2012 Jan 31;106(3):575-84
pubmed: 22233924
Occup Environ Med. 2020 May 12;:
pubmed: 32398292
Occup Environ Med. 2014 May;71(5):323-8
pubmed: 24436059
J Toxicol Environ Health B Crit Rev. 2016;19(5-6):173-189
pubmed: 27705544
Lancet Oncol. 2009 May;10(5):453-4
pubmed: 19418618
Int J Hyg Environ Health. 2017 Jul;220(5):857-868
pubmed: 28457891

Auteurs

Joachim Schüz (J)

International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Igor Bukhtiyarov (I)

Federal State Budgetary Scientific Institution "Izmerov Research Institute of Occupational Health" (IRIOH), Moscow, the Russian Federation.
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, the Russian Federation.

Ann Olsson (A)

International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Monika Moissonnier (M)

International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Evgenia Ostroumova (E)

International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Eleonora Feletto (E)

International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Cancer Council New South Wales, Cancer Research Division, Woolloomooloo, Australia.

Sara J Schonfeld (SJ)

International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

Graham Byrnes (G)

International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Iraklii Tskhomariia (I)

Federal State Budgetary Scientific Institution "Izmerov Research Institute of Occupational Health" (IRIOH), Moscow, the Russian Federation.

Valerie McCormack (V)

International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Kurt Straif (K)

International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Sergey Kashanskiy (S)

Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers, Yekaterinburg, the Russian Federation.

Tatiana Morozova (T)

I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, the Russian Federation.

Hans Kromhout (H)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.

Evgeny Kovalevskiy (E)

Federal State Budgetary Scientific Institution "Izmerov Research Institute of Occupational Health" (IRIOH), Moscow, the Russian Federation.
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, the Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH